You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

severe infection

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)

Not yet recruiting
  • Respiratory Syncytial Virus Infection
  • (no location specified)
Oct 6, 2023

Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide

Recruiting
  • Covid19
  • +3 more
  • Nitazoxanide and Ciclésonide
  • +3 more
  • Bobo-Dioulasso, Burkina Faso
  • +1 more
Jan 30, 2023

Study of MSC-Exo on the Therapy for Intensively Ill Children

Withdrawn
  • Sepsis
  • Critical Illness
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Jun 13, 2022

    COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)

    Recruiting
    • COVID-19
    • Umbilical cord mesenchymal stem cells implantation
    • Comparator
    • Shijiazhuang, Hebei, China
      The First Hospital of Hebei Medical University
    Feb 22, 2023

    Nutritional Indices on the Prognosis of SARS-CoV-2 Infection

    Recruiting
    • COVID-19
      • Chongqing, Chongqing, China
        The Second Affiliated Hospital of Chongqing Medical University
      Apr 27, 2023

      Symphony IL-6 Study in Patients at Risk of Severe Sepsis

      Recruiting
      • Severe Sepsis
        • Ann Arbor, Michigan
          University of Michigan Medical Center
        Dec 27, 2022

        T2 and SeptiCyte RAPID Duration Project

        Recruiting
        • Bacteremia
          • Brisbane, Queensland, Australia
          • +2 more
          Mar 15, 2022

          COVID-19 Respiratory Infection Trial (Azvudine, Placebo)

          Not yet recruiting
          • COVID-19 Respiratory Infection
          • (no location specified)
          Jan 17, 2023

          Course of COVID-19 Infection in Hospitalised Patients

          Completed
          • Covid19
          • SARS-CoV Infection
          • Chitotriosidase activity
          • Moscow, Russian Federation
          • +1 more
          Jan 24, 2023

          Severe Acute Respiratory Infections in Belgium

          Completed
          • Influenza Viral Infections
          • +2 more
          • respiratory specimen
          • (no location specified)
          Nov 11, 2022

          Influenza-like Illness (Including COVID-19)

          Suspended
          • Influenza
          • +7 more
          • Respiratory infections
          • London, United Kingdom
            Imperial College London
          Jul 27, 2022

          Oropharyngeal Candidiasis (OPC) and S-ECC

          Recruiting
          • Candida Infection
          • +2 more
            • Philadelphia, Pennsylvania
              University of Pennsylvania
            Mar 10, 2023

            / Pharmacodynamic Data and Interest Individualized Therapeutic

            Active, not recruiting
            • Severe Infection
            • Drug Monitoring
            • Paris, Ile-de-France, France
              Groupe Hospitalier Paris Saint Joseph
            Mar 30, 2022

            SARS-CoV Infection, COVID-19 Trial (Mitoquinone/mitoquinol mesylate, Placebo)

            Not yet recruiting
            • SARS-CoV Infection
            • COVID-19
            • Mitoquinone/mitoquinol mesylate
            • Placebo
            • (no location specified)
            Jun 1, 2023

            Severe Acute Respiratory Infection, Community-acquired Pneumonia, Respiratory Tract Infections Trial in Jinan (mNGS-guided

            Recruiting
            • Severe Acute Respiratory Infection
            • +4 more
            • mNGS-guided treatment
            • Jinan, Shandong, China
              Qilu Hospital of Shandong university
            Jan 28, 2023

            Peripheral Blood and Tissue Myeloid Cells. Phenotype for

            Recruiting
            • COVID-19 Pneumonia
            • Immune-phenotyping of tissue and peripheral blood myeloid compartment
            • Roma, Lazio, Italy
            • +1 more
            Mar 2, 2023

            COVID 19 Trial in Nancy (Cognitive assessment, Imaging, Routine care)

            Recruiting
            • COVID 19
            • Cognitive assessment
            • +3 more
            • Nancy, France
              Nancy University Hospital, Department of Neurology
            Jul 20, 2022

            Treating Genital Herpes Infection to Reduce Racial Disparities

            Not yet recruiting
            • Genital Herpes Simplex
            • +2 more
              • Oakland, California
                Division of Research, Kaiser Permanente Northern California
              Jun 22, 2022

              Assess Infection Rate of Severe Acute Respiratory Syndrome -

              Completed
              • Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
                • Chicago, Illinois
                  Great Lakes Clinical Trials /ID# 224874
                Oct 6, 2022

                Pneumonitis, SARS-CoV Infection Trial in Worldwide (GLS-1027, Placebo)

                Active, not recruiting
                • Pneumonitis
                • SARS-CoV Infection
                • Baton Rouge, Louisiana
                • +16 more
                Jan 10, 2023

                HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

                Not yet recruiting
                • HIV-1-infection
                • +2 more
                • CAB + RPV
                • (no location specified)
                Nov 16, 2022

                Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

                Active, not recruiting
                • Hematopoietic and Lymphoid Cell Neoplasm
                • +2 more
                • Best Practice
                • +2 more
                • Duarte, California
                  City of Hope Medical Center
                Dec 8, 2022

                COVID-19 Trial (Azvudine, Nirmatrelvir-Ritonavir)

                Not yet recruiting
                • COVID-19
                • (no location specified)
                Jan 25, 2023

                Antithrombin III Treatment in Severe COVID-19 Infection

                Active, not recruiting
                • Covid19
                • Antithrombin III
                • Innsbruck, Austria
                • +5 more
                Aug 1, 2022

                Coronavirus Infection Trial (Selinexor)

                Withdrawn
                • Coronavirus Infection
                • (no location specified)
                Jan 19, 2023